{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-052948","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2023-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.184105+00:00","generated_at":"2026-06-13T14:50:04.829065+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Silo Pharma extends license agreement with University of Maryland through Sept 2023, with option to Dec 2023","bullets":["Term of Commercial Evaluation and License Agreement extended to September 30, 2023.","Company may further extend to December 31, 2023 by paying $2,500 fee and providing notice by August 31, 2023.","Amendment executed June 28, 2023; fee creditable against future patent expenses if master license signed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-052948","json":"https://secwatch.observer/filing/0001213900-23-052948.json","markdown":"https://secwatch.observer/filing/0001213900-23-052948.md","text":"https://secwatch.observer/filing/0001213900-23-052948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023052948/0001213900-23-052948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023052948/ea181159-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T14:50:04.829065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}